Track the 현대약품 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 현대약품 has logged 1 reports. Market capitalisation: €163.5bn. The latest transaction was reported on 4 March 2026 (Purchase). Among the most active insiders: 신풍제약. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Hyundai Pharmaceutical es una empresa surcoreana especializada en el sector sanitario y farmacéutico. Cotiza en el XKRX.